Key result
TAVR achieves ~87% technical success in patients with coronary artery anomalies.
Why the study?
The incidence and potential implications of coronary artery anomalies in patients undergoing TAVR were uncertain.
Does transcatheter aortic valve replacement cause procedural complications in patients with coronary artery anomalies?
Observational (n=15)
No
Does transcatheter aortic valve replacement cause procedural complications in patients with coronary artery anomalies?
Coronary artery anomalies are present in roughly 0.7% of TAVR patients and can lead to severe complications like coronary occlusion if not recognized and managed appropriately.
TAVR feasible in CAA patients; leaves open optimal screening and management in prospective studies.
Background The incidence and possible implications of coronary artery anomalies (CAA) in patients undergoing transcatheter aortic valve replacement (TAVR) are uncertain. Aims To evaluate the impact of CAA on TAVR outcomes, and to suggest possible strategies to prevent CAA related complications. Methods Among 2,164 consecutive patients who underwent TAVR in our center, 15 (0.69%) were identified to have a CAA, based on pre-operative Computed Tomography (CT) scans. Results CT-angiography revealed the following features of CAA: the majority of anomalous CAA concerned the right coronary artery (80%), followed by the left main (13.3%) and the left circumflex (6.7%). An intramural course was observed only in 26.7% patients, whereas an acute take-off was detected in more than half of the study cohort (53.3%). High-risk sudden cardiac death features were observed in 6 (40%) patients. Technical success was 86.7%, device success was 80%. One patient experienced a cardiac arrest 15 minutes after procedure, resulting from occlusion of the anomalous right coronary artery with the ostium located at the right-to-non coronary commissure. There were no cases of ≥ moderate paravalvular leak or stroke. One non-cardiac related death was recorded 4 months after the procedure. Conclusions The interaction between transcatheter bioprosthesis and different CAA types could lead to ominous sequelae, if not promptly recognized and treated accordingly.
No takes yet. Share an insight, caveat, or question.
Oliva et al. (2023) conducted an observational in Severe aortic stenosis with coronary artery anomalies (n=15). Transcatheter aortic valve replacement (TAVR) was evaluated on Technical success (VARC-3 criteria). Transcatheter aortic valve replacement in patients with coronary artery anomalies achieved a technical success rate of 86.7% and a device success rate of 80%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: